Allodynic Therapeutics, Inc — Biomedical Watch V2

Traitements10programmes

Essais4liés

Publications0liées

SourceDBlocale

Traitements

10

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Acetaminophen AloneThe study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.	Migraine	Phase 2	À vérifier	United States	À vérifier
Low-Dose Naltrexone and Acetaminophen CombinationThe Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetaminophen Combination: A Small, Randomized, Double-Blind, and Placebo-Controlled Clinical Trial with an Open-Label Extension for None-Responders	Migraine	Phase 2	À vérifier	United States	À vérifier
Naltrexone Alone (regular dose)The study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.	Migraine	Phase 2	À vérifier	United States	À vérifier
Naltrexone and AcetaminophenThe study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.	Migraine	Phase 2	À vérifier	United States	À vérifier
Naltrexone and Acetaminophen CombinationThis proof-of-concept study compares side-by-side low-dose naltrexone and acetaminophen combination to sumatriptan in the acute treatment of migraine.	Migraine	Phase 2/3	À vérifier	United States	À vérifier
Naltrexone and Acetaminophen-High DoseThe study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.	Migraine	Phase 2	À vérifier	United States	À vérifier
Low-Dose Naltrexone and Acetaminophen CombinationThe Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetaminophen Combination: A Small, Randomized, Double-Blind, and Placebo-Controlled Clinical Trial with an Open-Label Extension for None-Responders	Migraine	Phase 2	À vérifier	United States	À vérifier
Naltrexone and AcetaminophenThe study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.	Migraine	Phase 2	À vérifier	United States	À vérifier
Naltrexone and Acetaminophen CombinationThis proof-of-concept study compares side-by-side low-dose naltrexone and acetaminophen combination to sumatriptan in the acute treatment of migraine.	Migraine	Phase 2/3	À vérifier	United States	À vérifier
Naltrexone and AcetaminophenThe study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.	Migraine	Phase 2	À vérifier	United States	À vérifier

Essais cliniques

4

Molécule	Indication / population	Phase	NCT	Titre	Statut
Naltrexone and Acetaminophen	Migraine	Phase 2	NCT03061734	ANODYNE-1 — Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine	COMPLETED
Naltrexone and Acetaminophen Combination	Migraine	Phase 2/3	NCT03185143	Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea	COMPLETED
Naltrexone and Acetaminophen	Migraine	Phase 2	NCT06245902	ANODYNE-1 — An Acute Migraine Factorial Study	COMPLETED
Low-Dose Naltrexone and Acetaminophen Combination	Migraine	Phase 2	NCT03194555	The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.